Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc interventions image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Intv, 2009; 2:357-363, doi:10.1016/j.jcin.2009.01.008
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Samady, H.
Right arrow Articles by Vaccarino, V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Samady, H.
Right arrow Articles by Vaccarino, V.
Related Collections
Right arrowRelated Article

Clinical Research

Baseline Fractional Flow Reserve and Stent Diameter Predict Optimal Post-Stent Fractional Flow Reserve and Major Adverse Cardiac Events After Bare-Metal Stent Deployment

Habib Samady, MD*,*, Michael McDaniel, MD*, Emir Veledar, PhD*, Bernard De Bruyne, MD, PhD{ddagger}, Nico H. Pijls, MD, PhD{dagger}, William F. Fearon, MD§, Viola Vaccarino, MD, PhD*

* Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
{dagger} Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands
{ddagger} Cardiovascular Center, Aalst, Belgium
§ Stanford University, Stanford, California

* Reprint requests and correspondence: Dr. Habib Samady, Associate Professor of Medicine, Emory University School of Medicine, Suite F606, 1365 Clifton Road, Atlanta, Georgia (Email: hsamady{at}emory.edu).

Objectives: We sought to identify baseline clinical, angiographic, and hemodynamic variables associated with optimal bare-metal stent (BMS) deployment, allowing selection of patients for treatment with BMS.

Background: Patients with fractional flow reserve (FFR) >0.90 after BMS have low (<6%) major adverse cardiac event rates (MACE). We hypothesized that baseline variables can predict post-stent FFR >0.90 and MACE after BMS.

Methods: In 586 patients from the multicenter post-BMS FFR registry, we developed multivariable logistic regression models to identify clinical, angiographic, and hemodynamic variables associated with post-stent FFR ≥0.90 and 6-month MACE.

Results: After adjusting for potential confounders, baseline FFR (odds ratio [OR]: 5.0) and stent diameter (OR: 2.5 per millimeter) were predictive of post-stent FFR >0.90. Lower FFR (OR: 7.8); smaller stent diameter (OR: 3.7 per millimeter); longer stent length (OR: 1.0 per millimeter); and larger minimal luminal diameter (OR: 2.2 per millimeter) were predictors of MACE. In patients receiving 3-mm diameter stents, baseline FFR >0.70 yielded significantly higher likelihood of achieving post-stent FFR >0.90 than baseline FFR ≤0.70 (77% vs. 63%, p < 0.05); and in patients receiving <3-mm diameter stents, baseline FFR <0.50 was associated with higher MACE than FFR 0.50 to 0.70, and FFR >0.70 (40% vs. 15% vs. 13%, p < 0.05).

Conclusions: In patients receiving BMS, baseline FFR and stent diameter are predictors of post-stent FFR >0.90; and baseline FFR, stent diameter, stent length, and minimal luminal diameter are predictors of MACE. These variables may allow selection of patients who will have excellent results with BMS.

Key Words: fractional flow reserve • bare-metal stents • percutaneous coronary interventions • moderate coronary lesion assessment

Abbreviations and Acronyms
  ATP = adenosine triphosphate
  BMS = bare-metal stent(s)
  DES = drug-eluting stent(s)
  FFR = fractional flow reserve
  MACE = major adverse cardiac event(s)
  MLD = minimal luminal diameter
  PCI = percutaneous coronary intervention


Related Article

Baseline Fractional Flow Reserve and Stent Diameter Predict Event Rates After Stenting: A Further Step, But Still Much to Learn
Massoud A. Leesar
J. Am. Coll. Cardiol. Intv. 2009 2: 364-365. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. J. Kern and H. Samady
Current Concepts of Integrated Coronary Physiology in the Catheterization Laboratory
J. Am. Coll. Cardiol., January 19, 2010; 55(3): 173 - 185.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
M. A. Leesar
Baseline Fractional Flow Reserve and Stent Diameter Predict Event Rates After Stenting: A Further Step, But Still Much to Learn
J. Am. Coll. Cardiol. Intv., April 1, 2009; 2(4): 364 - 365.
[Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link